Non-thermal plasmas: novel preventive and curative therapy against melanomas?

Franck Gesbert1, Lionel Larue

  • 1Institut Curie, Normal and Pathological Development of Melanocytes, Orsay, France; CNRS UMR3347, Orsay, France; INSERM U1021, Orsay, France; Equipe labellisée - Ligue Nationale contre le Cancer, Orsay, France; University of Paris-Sud, Orsay, France.

Insights

Non-equilibrium atmospheric pressure plasma (NEAPP) shows promise for treating melanoma. This physics-based approach is being explored for its potential in preventing cancer recurrence after surgery.

Area of Science:

  • Oncology
  • Plasma Physics
  • Dermatology

Background:

  • Malignant melanoma is an aggressive cancer with poor prognosis, especially after metastasis.
  • Adjuvant therapies post-surgery have historically been limited, with chemotherapy and immunotherapy offering incomplete solutions.
  • New therapeutic strategies are crucial for improving outcomes in melanoma treatment.

Purpose of the Study:

  • To explore the potential of non-equilibrium atmospheric pressure plasma (NEAPP) as a novel treatment modality for melanoma.
  • To assess the efficacy of NEAPP in a preventive context for pre-cancerous lesions.

Main Methods:

  • Utilizing non-equilibrium atmospheric pressure plasma (NEAPP) technology.
  • Application of NEAPP on melanoma cells to evaluate curative potential.
  • Investigating NEAPP application on benign nevi as a preventive measure.

Main Results:

  • NEAPP demonstrated initial curative potential against melanoma cancer cells.
  • Yajima et al. recently applied NEAPP to benign nevi, exploring its preventive capabilities.

Conclusions:

  • Non-equilibrium atmospheric pressure plasma (NEAPP) presents a novel physics-based approach for cancer therapy.
  • Further research into NEAPP for melanoma treatment and prevention is warranted.

Related Concept Videos